The health system said pandemic relief funds helped offset the net loss for the first quarter of 2022 by $35 million.
CHS, an 83-hospital system, had $3.1 billion in net operating revenue for the first quarter of 2022, a 3.3 percent increase from the $3 billion reported for the same period last year.
Operating costs and expenses also rose year over year, by 5.7 percent, to $2.8 billion in the first quarter of 2022 from $2.7 billion last year. Salaries and benefits represented a large share of expenses, accounting for more than $1.3 billion in the first quarter of 2022, a 1.7 percent increase from the same period last year.
The system posted a 17.2 percent decrease in its operating income, to $270 million for the three months ended March 31, compared to $326 million for the same period last year.
The COVID-19 surge early in the year hurt revenue and expenses, but the system’s financial performance improved toward the end of the quarter, as patient volume returned and pandemic expenses leveled, CHS CEO Tim Hingtgen said in the report.
“Moving through the second quarter and the remainder of the year, we anticipate contract labor rates to remain elevated. However, we expect our operational momentum to continue, as we anticipate capturing deferred healthcare demand, benefiting from recent strategic investments, and continuing the execution of the company’s margin improvement program,” he added.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
